Single-Dual Task Performance in Children With Autism Spectrum Disorder and Typically Developing Children

NCT ID: NCT07323550

Last Updated: 2026-01-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

90 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-09-01

Study Completion Date

2026-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to compare the effects of single-task and dual-task conditions on motor performance and postural control in children with Autism Spectrum Disorder (ASD) and typically developing children. Participants' performance under single-task and dual-task conditions involving cognitive load will be evaluated to examine how cognitive demands affect physical task performance in both groups.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Autism Dual Task

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Autism Spectrum Disorder

The diagnosis of Autism Spectrum Disorder was made by child and adolescent psychiatrists in accordance with the Diagnostic and Statistical Manual of Mental Disorders - Fifth Edition (DSM-5) diagnostic criteria.

Single- and Dual-Task Condition Assessment

Intervention Type OTHER

Participants will perform motor tasks under single-task and dual-task conditions. In the dual-task condition, a concurrent cognitive task will be added to the motor task to increase cognitive load. Performance during these conditions will be assessed to examine the effects of cognitive load on motor performance and postural control. No therapeutic intervention, medication, or device is applied.

Typically developing child

A control group consisting of children with normal development, matched to the OSB group in terms of age and gender variables, was included.

Single- and Dual-Task Condition Assessment

Intervention Type OTHER

Participants will perform motor tasks under single-task and dual-task conditions. In the dual-task condition, a concurrent cognitive task will be added to the motor task to increase cognitive load. Performance during these conditions will be assessed to examine the effects of cognitive load on motor performance and postural control. No therapeutic intervention, medication, or device is applied.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Single- and Dual-Task Condition Assessment

Participants will perform motor tasks under single-task and dual-task conditions. In the dual-task condition, a concurrent cognitive task will be added to the motor task to increase cognitive load. Performance during these conditions will be assessed to examine the effects of cognitive load on motor performance and postural control. No therapeutic intervention, medication, or device is applied.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Autism Spectrum Disorder (ASD) Group:
* Aged between 5 and 16 years
* Diagnosed with mild to moderate Autism Spectrum Disorder based on Childhood Autism Rating Scale (CARS) scores
* Ability to understand basic visual, auditory, and verbal instructions
* Sufficient cognitive capacity to follow dual-task instructions

Typically Developing Control Group:

* Age- and sex-matched with the ASD group
* No history of neurological, psychiatric, sensory, orthopedic, or developmental disorders
* No acute or chronic medical conditions
* No pain complaints during assessment
* Written informed consent obtained from a legal guardian

Exclusion Criteria

Both Groups:

* History of neurological disorders, epilepsy, or seizures
* Orthopedic or musculoskeletal conditions affecting balance
* Visual or hearing impairments (except corrected vision or hearing with glasses or hearing aids)
* Use of assistive devices for walking or balance
* Use of medications affecting balance or motor performance
* Presence of comorbid psychiatric disorders
* Inability to cooperate adequately during assessment
* Absence from more than two consecutive assessment sessions
* Participation in another intervention program during the study period
Minimum Eligible Age

5 Years

Maximum Eligible Age

16 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Atlas University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Gamze Demircioğlu

Ass.prof.

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Moren Language, Speech, and Development Center

Ordu, , Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Gamze Demircioglu, PhD

Role: CONTACT

+905348689544

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Gamze Demircioglu, PhD

Role: primary

05348689544

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024-ATLAS-MSEHF-003

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.